LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...

LVR-KLINIKUM DÜsseLDORF – hOsPITaL OF The heINRIch-heINe UNIVeRsITY DÜsseLDORF
Wölwer W, Brinkmeyer J, Riesbeck M, Freimüller L, Möller HJ,
Klingberg S, Gaebel W & German Study Group on First Episode
Schizophrenia (2008): Neuropsychological impairments predict the
clinical course in schizophrenia. Eur Arch Psychiat Clin Neurosc
258: 28–34
Wölwer W, Frommann N (2008): Therapie von sozial-kognitiven Störungen:
Das Training der Affektdekodierung als funktionsspezifischer
Ansatz. Nervenheilkunde 27: 1032–1038
Wölwer W, Klingberg S (2008): (Editorial): Psychotherapie bei Psychosen.
Nervenheilkunde 27: 971–972
Wüllner U, Gündisch D, Herzog H, Minnerop M, Joe A, Warnecke
M, Jessen F, Schütz C, Reinhardt M, Eschner W, Klockgether T,
Schmaljohann J (2008): Smoking upregulates alpha4beta2* nicotinic
acetylcholine receptors in the human brain. Neurosci Lett 430:
34–37
Zielasek J, Gaebel W (2008): Modern modularity and the road
towards a modular psychiatry. Eur Arch Psychiatry Clin Neurosci
258 (Suppl 5): 60–65
Zielasek J (2008): Psychiatric Aspects of Neurologic Diseases:
Practical Approaches to Patient Care. Book Review. Arch Neurol
65: 1543–1544
2009
Bermejo I, Schneider F, Gaebel W, Hegerl U, Berger M, Härter M
(2008): Improving outpatient care of depression by implementing
practice guidelines. Int J Qual in Health Care 21: 29–36
Breitling LP, Dahmen N, Mittelstrass K, Illig T, Rujescu D, Raum E,
Winterer G, Brenner H (2009): Smoking cessation and variations
in nicotinic acetylcholine receptor subunits alpha-5, alpha-3, and
beta-4 genes. Biol Psychiatry 65: 691–695
Cordes J, Falkai P, Guse B, Hasan A, Schneider-Axmann T, Arends
M, Winterer G, Wölwer W, Ben Sliman E, Ramacher M, Schmidt-
Kraepelin C, Ohmann C, Langguth B, Landgrebe M, Eichhammer
P, Frank E, Burger J, Hajak G, Rietschel M, Wobrock T (2009): Repetitive
transcranial magnetic stimulation (rTMS) for the treatment
of negative symptoms in residual schizophrenia – rationale and
design of a sham-controlled, randomised multicenter study. Europ
Arch Psych Clin Neur 259 (Suppl): 189–197
Cordes J, Larisch R, Henning U, Thünker J, Werner Ch, Orozco G,
Mayoral F, Rivas F, Auburger G, Tosch M, Rietschel M, Gaebel W,
Muller HW, Klimke A (2009): Abnormal neuroendocrine resonse
to clomipramine in hereditary affective psychosis. Depression and
Anxiety 26: 111–119
Cordes J, Thünker J, Agelink MW, Arends M, Mobascher A, Wobrock
T, Schneider-Axmann T, Brinkmeyer J, Mittrach M, Regenbrecht
G, Wölwer W, Winterer G, Gaebel W (2009): Effects of 10 Hz repetitive
transcranial magnetic stimulation (rTMS) on clinical global
impression in chronic schizophrenia; dio:10.1016/i.psychres.2009.01.014
134
Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW,
Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libi-
ger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W,
Peuskens J, Lindefors N, Riecher-Rössler A, Kahn RS (2009): Cognitive
effects of antipsychotic drugs in first-episode schizophrenia
and schizophreniform disorder: a randomized, open-label clinical
trial (EUFEST). Am J Psychiatry 166: 675–682
Ferrea S, Fehsel K, Cordes J, Luckhaus C (2009): Circadian rhythm of
neutrophil count and granulocyte macrophage-colony stimulating
factor (GM-CSF) in blood under initial clozapine treatment. World J
Biol Psychiatry 24: 1–3
Gaebel W (2009): Von Krankheit und Kranksein. Gehirn & Geist 1–2:
40–41
Gaebel W (2009): Bericht des Präsidenten der DGPPN 2007–2008.
Nervenarzt 80: 215–219
Gaebel W, Janssen B, Zielasek J (2009): Mental health quality, outcome
measurement, and improvement in Germany. Curr Opin
Psychiatry 22: 636–642
Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff
M, Lemke M, Heuser I, Maier W, Huff W, Schmitt A, Sauer
H, Riedel M, Klingberg S, Köpcke W, Ohmann C, Möller HJ (2009):
German Study Group on First-Episode Schizophrenia. Relapse
prevention in first-episode schizophrenia: Maintenance vs. intermittent
drug treatment with prodrome-based early intervention.
Results of a randomized controlled trial within the German Research
Network on Schizophrenia. J Clin Psychiatry (in press)
Gaebel W, Zielasek J (2009): Future classification of pschotic disorders.
Eur Arch Psychiatry Clin Neurosci 259 (Suppl): 213–218
Gaebel W, Zielasek J (2009): Editorial: Psychiatry as a therapeutic
discipline. Eur Arch Psychiatry Clin Neurosci 259 (Suppl): 107
Gaebel W, Zielasek J, Cleveland H (2009): Psychiatry as a medical
speciality: challenges and opportunities. World Psychiatry (in
press)
Gescher DM, Malevani J (2009): Moodstabilizer in the Psychopharmacotherapy
of Borderline Personality Disorder. Fortschr Neurol
Psychiatr 77: 389–398
Görtz P, Opatz J, Siebler M, Funke SA, Willbold D, Lange-Asschenfeldt
C (2009): Transient reduction of spontaneous neuronal network
activity by sublethal amyloid ß (1–42) concentrations. J Neural
Transm 116: 351–355
Gummersbach C, Hemmrich K, Kröncke KD, Suschek CV, Fehsel K,
Pallua N (2009): New aspects of adipogenesis: radicals and oxidative
stress. Differentiation 77: 115–120
Habel U, Koch K, Kellermann T, Reske M, Frommann N, Wölwer W,
Shah J, Schneider F (2009): Training of Affect Recognition in schizophrenia:
Neurobehavioral validation. Social Neuroscience Oct 9:
(epub ahead of print)
Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C,
Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr
A, Möller HJ, Riedel M (2009): Does early improvement triggered
by antidepressants predict response/remission? – Analsis of data